Fluorine in PDB 7wym: Structure of the Sars-Cov-2 Main Protease with 337 Inhibitor
Enzymatic activity of Structure of the Sars-Cov-2 Main Protease with 337 Inhibitor
All present enzymatic activity of Structure of the Sars-Cov-2 Main Protease with 337 Inhibitor:
3.4.22.69;
Protein crystallography data
The structure of Structure of the Sars-Cov-2 Main Protease with 337 Inhibitor, PDB code: 7wym
was solved by
B.Qin,
P.Hou,
X.Gao,
S.Cui,
with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:
Resolution Low / High (Å)
|
56.26 /
2.05
|
Space group
|
C 1 2 1
|
Cell size a, b, c (Å), α, β, γ (°)
|
114.715,
53.717,
44.775,
90,
101.24,
90
|
R / Rfree (%)
|
19.4 /
22.1
|
Fluorine Binding Sites:
The binding sites of Fluorine atom in the Structure of the Sars-Cov-2 Main Protease with 337 Inhibitor
(pdb code 7wym). This binding sites where shown within
5.0 Angstroms radius around Fluorine atom.
In total 3 binding sites of Fluorine where determined in the
Structure of the Sars-Cov-2 Main Protease with 337 Inhibitor, PDB code: 7wym:
Jump to Fluorine binding site number:
1;
2;
3;
Fluorine binding site 1 out
of 3 in 7wym
Go back to
Fluorine Binding Sites List in 7wym
Fluorine binding site 1 out
of 3 in the Structure of the Sars-Cov-2 Main Protease with 337 Inhibitor
Mono view
Stereo pair view
|
A full contact list of Fluorine with other atoms in the F binding
site number 1 of Structure of the Sars-Cov-2 Main Protease with 337 Inhibitor within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:F401
b:83.2
occ:1.00
|
F01
|
A:G7L401
|
0.0
|
83.2
|
1.0
|
C09
|
A:G7L401
|
1.4
|
84.0
|
1.0
|
F03
|
A:G7L401
|
2.2
|
87.0
|
1.0
|
F02
|
A:G7L401
|
2.2
|
83.9
|
1.0
|
C08
|
A:G7L401
|
2.4
|
81.0
|
1.0
|
HG2
|
A:MET165
|
2.4
|
62.1
|
0.5
|
HE3
|
A:MET165
|
2.9
|
72.8
|
0.5
|
N02
|
A:G7L401
|
3.1
|
76.7
|
1.0
|
CG
|
A:MET165
|
3.1
|
51.6
|
0.5
|
HA
|
A:ASP187
|
3.2
|
43.3
|
1.0
|
SD
|
A:MET165
|
3.3
|
57.1
|
0.5
|
HB2
|
A:ASP187
|
3.4
|
43.6
|
1.0
|
C07
|
A:G7L401
|
3.4
|
77.9
|
1.0
|
HB3
|
A:MET165
|
3.5
|
55.9
|
0.5
|
HD2
|
A:HIS41
|
3.5
|
46.7
|
1.0
|
HG3
|
A:MET165
|
3.5
|
62.1
|
0.5
|
CE
|
A:MET165
|
3.6
|
60.5
|
0.5
|
HE2
|
A:MET165
|
3.7
|
62.9
|
0.5
|
H9
|
A:G7L401
|
3.7
|
93.7
|
1.0
|
C
|
A:ASP187
|
3.7
|
43.8
|
1.0
|
CA
|
A:ASP187
|
3.8
|
36.0
|
1.0
|
CD2
|
A:HIS41
|
3.8
|
38.8
|
1.0
|
N
|
A:ARG188
|
3.9
|
48.1
|
1.0
|
CB
|
A:ASP187
|
3.9
|
36.1
|
1.0
|
H
|
A:ARG188
|
4.1
|
57.9
|
1.0
|
HE1
|
A:MET165
|
4.1
|
72.8
|
0.5
|
HA
|
A:ARG188
|
4.1
|
61.5
|
1.0
|
O
|
A:ASP187
|
4.1
|
40.5
|
1.0
|
HB2
|
A:MET165
|
4.1
|
55.9
|
0.5
|
HB3
|
A:ASP187
|
4.2
|
43.6
|
1.0
|
CB
|
A:MET165
|
4.2
|
46.4
|
0.5
|
C06
|
A:G7L401
|
4.3
|
73.3
|
1.0
|
HE2
|
A:MET165
|
4.3
|
72.8
|
0.5
|
CG
|
A:HIS41
|
4.3
|
47.0
|
1.0
|
HB3
|
A:MET165
|
4.3
|
55.9
|
0.5
|
NE2
|
A:HIS41
|
4.4
|
36.6
|
1.0
|
CB
|
A:MET165
|
4.4
|
46.4
|
0.5
|
HB3
|
A:HIS41
|
4.4
|
52.2
|
1.0
|
CA
|
A:ARG188
|
4.4
|
51.1
|
1.0
|
HE2
|
A:HIS41
|
4.5
|
44.2
|
1.0
|
C
|
A:ARG188
|
4.5
|
51.8
|
1.0
|
HB2
|
A:HIS41
|
4.5
|
52.2
|
1.0
|
CE
|
A:MET165
|
4.5
|
52.3
|
0.5
|
O
|
A:HIS164
|
4.6
|
35.7
|
1.0
|
HB3
|
A:HIS164
|
4.7
|
42.8
|
1.0
|
S01
|
A:G7L401
|
4.7
|
76.3
|
1.0
|
HH
|
A:TYR54
|
4.7
|
47.8
|
1.0
|
CB
|
A:HIS41
|
4.7
|
43.3
|
1.0
|
O
|
A:ARG188
|
4.7
|
45.5
|
1.0
|
HA
|
A:MET165
|
4.8
|
48.9
|
1.0
|
HG2
|
A:MET49
|
4.9
|
93.4
|
1.0
|
HE1
|
A:MET165
|
4.9
|
62.9
|
0.5
|
SD
|
A:MET165
|
4.9
|
62.1
|
0.5
|
OH
|
A:TYR54
|
4.9
|
39.7
|
1.0
|
|
Fluorine binding site 2 out
of 3 in 7wym
Go back to
Fluorine Binding Sites List in 7wym
Fluorine binding site 2 out
of 3 in the Structure of the Sars-Cov-2 Main Protease with 337 Inhibitor
Mono view
Stereo pair view
|
A full contact list of Fluorine with other atoms in the F binding
site number 2 of Structure of the Sars-Cov-2 Main Protease with 337 Inhibitor within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:F401
b:83.9
occ:1.00
|
F02
|
A:G7L401
|
0.0
|
83.9
|
1.0
|
C09
|
A:G7L401
|
1.4
|
84.0
|
1.0
|
F01
|
A:G7L401
|
2.2
|
83.2
|
1.0
|
F03
|
A:G7L401
|
2.2
|
87.0
|
1.0
|
C08
|
A:G7L401
|
2.4
|
81.0
|
1.0
|
H9
|
A:G7L401
|
2.6
|
93.7
|
1.0
|
C07
|
A:G7L401
|
2.8
|
77.9
|
1.0
|
HG2
|
A:MET49
|
2.8
|
93.4
|
1.0
|
HA
|
A:ARG188
|
3.3
|
61.5
|
1.0
|
HB3
|
A:MET49
|
3.3
|
93.0
|
1.0
|
HB2
|
A:HIS41
|
3.4
|
52.2
|
1.0
|
N02
|
A:G7L401
|
3.6
|
76.7
|
1.0
|
CG
|
A:MET49
|
3.7
|
77.7
|
1.0
|
O
|
A:ASP187
|
3.7
|
40.5
|
1.0
|
HH
|
A:TYR54
|
3.7
|
47.8
|
1.0
|
HB3
|
A:HIS41
|
3.7
|
52.2
|
1.0
|
OH
|
A:TYR54
|
3.9
|
39.7
|
1.0
|
C
|
A:ASP187
|
3.9
|
43.8
|
1.0
|
HB2
|
A:ASP187
|
3.9
|
43.6
|
1.0
|
CB
|
A:MET49
|
3.9
|
77.4
|
1.0
|
CB
|
A:HIS41
|
3.9
|
43.3
|
1.0
|
HA
|
A:MET49
|
3.9
|
83.1
|
1.0
|
CA
|
A:ARG188
|
4.0
|
51.1
|
1.0
|
N
|
A:ARG188
|
4.1
|
48.1
|
1.0
|
CG
|
A:HIS41
|
4.1
|
47.0
|
1.0
|
HD2
|
A:HIS41
|
4.3
|
46.7
|
1.0
|
CD2
|
A:HIS41
|
4.3
|
38.8
|
1.0
|
HG3
|
A:MET49
|
4.4
|
93.4
|
1.0
|
H
|
A:GLN189
|
4.4
|
61.1
|
1.0
|
SD
|
A:MET49
|
4.4
|
110.8
|
1.0
|
CA
|
A:MET49
|
4.4
|
69.1
|
1.0
|
S01
|
A:G7L401
|
4.4
|
76.3
|
1.0
|
HE3
|
A:MET165
|
4.4
|
72.8
|
0.5
|
C
|
A:ARG188
|
4.5
|
51.8
|
1.0
|
O
|
A:MET49
|
4.5
|
58.4
|
1.0
|
HA
|
A:ASP187
|
4.5
|
43.3
|
1.0
|
HG3
|
A:PRO52
|
4.5
|
65.3
|
1.0
|
N
|
A:GLN189
|
4.6
|
50.8
|
1.0
|
HG2
|
A:MET165
|
4.6
|
62.1
|
0.5
|
CA
|
A:ASP187
|
4.6
|
36.0
|
1.0
|
HE2
|
A:MET49
|
4.6
|
103.9
|
1.0
|
C06
|
A:G7L401
|
4.6
|
73.3
|
1.0
|
H
|
A:ARG188
|
4.7
|
57.9
|
1.0
|
CB
|
A:ASP187
|
4.7
|
36.1
|
1.0
|
HB2
|
A:MET49
|
4.7
|
93.0
|
1.0
|
ND1
|
A:HIS41
|
4.8
|
42.6
|
1.0
|
HB2
|
A:GLN189
|
4.8
|
69.4
|
1.0
|
|
Fluorine binding site 3 out
of 3 in 7wym
Go back to
Fluorine Binding Sites List in 7wym
Fluorine binding site 3 out
of 3 in the Structure of the Sars-Cov-2 Main Protease with 337 Inhibitor
Mono view
Stereo pair view
|
A full contact list of Fluorine with other atoms in the F binding
site number 3 of Structure of the Sars-Cov-2 Main Protease with 337 Inhibitor within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:F401
b:87.0
occ:1.00
|
F03
|
A:G7L401
|
0.0
|
87.0
|
1.0
|
C09
|
A:G7L401
|
1.4
|
84.0
|
1.0
|
F01
|
A:G7L401
|
2.2
|
83.2
|
1.0
|
F02
|
A:G7L401
|
2.2
|
83.9
|
1.0
|
C08
|
A:G7L401
|
2.4
|
81.0
|
1.0
|
HE3
|
A:MET165
|
2.6
|
72.8
|
0.5
|
N02
|
A:G7L401
|
2.9
|
76.7
|
1.0
|
HB2
|
A:GLN189
|
3.1
|
69.4
|
1.0
|
N
|
A:GLN189
|
3.2
|
50.8
|
1.0
|
C
|
A:ARG188
|
3.3
|
51.8
|
1.0
|
HA
|
A:ARG188
|
3.3
|
61.5
|
1.0
|
HB3
|
A:MET49
|
3.3
|
93.0
|
1.0
|
HA
|
A:GLN189
|
3.4
|
72.9
|
1.0
|
H
|
A:GLN189
|
3.4
|
61.1
|
1.0
|
CE
|
A:MET165
|
3.5
|
60.5
|
0.5
|
C07
|
A:G7L401
|
3.6
|
77.9
|
1.0
|
CA
|
A:ARG188
|
3.7
|
51.1
|
1.0
|
CA
|
A:GLN189
|
3.7
|
60.6
|
1.0
|
O
|
A:ARG188
|
3.7
|
45.5
|
1.0
|
HE1
|
A:MET165
|
3.7
|
72.8
|
0.5
|
HG2
|
A:MET165
|
3.8
|
62.1
|
0.5
|
CB
|
A:GLN189
|
3.8
|
57.6
|
1.0
|
N
|
A:ARG188
|
3.9
|
48.1
|
1.0
|
H9
|
A:G7L401
|
3.9
|
93.7
|
1.0
|
HG2
|
A:MET49
|
4.1
|
93.4
|
1.0
|
H
|
A:ARG188
|
4.1
|
57.9
|
1.0
|
C06
|
A:G7L401
|
4.1
|
73.3
|
1.0
|
O
|
A:MET49
|
4.2
|
58.4
|
1.0
|
HE2
|
A:MET165
|
4.2
|
72.8
|
0.5
|
HB3
|
A:GLN189
|
4.2
|
69.4
|
1.0
|
CB
|
A:MET49
|
4.2
|
77.4
|
1.0
|
SD
|
A:MET165
|
4.3
|
57.1
|
0.5
|
C
|
A:ASP187
|
4.3
|
43.8
|
1.0
|
CG
|
A:MET165
|
4.5
|
51.6
|
0.5
|
HA
|
A:ASP187
|
4.6
|
43.3
|
1.0
|
CG
|
A:MET49
|
4.6
|
77.7
|
1.0
|
O
|
A:ASP187
|
4.7
|
40.5
|
1.0
|
S01
|
A:G7L401
|
4.7
|
76.3
|
1.0
|
HB2
|
A:MET165
|
4.7
|
55.9
|
0.5
|
HB3
|
A:MET165
|
4.8
|
55.9
|
0.5
|
HB2
|
A:MET49
|
4.8
|
93.0
|
1.0
|
HA
|
A:MET49
|
4.9
|
83.1
|
1.0
|
SD
|
A:MET49
|
4.9
|
110.8
|
1.0
|
HB3
|
A:MET165
|
4.9
|
55.9
|
0.5
|
|
Reference:
B.Qin,
G.B.Craven,
P.Hou,
J.Chesti,
X.Lu,
E.S.Child,
R.M.L.Morgan,
W.Niu,
L.Zhao,
A.Armstrong,
D.J.Mann,
S.Cui.
Acrylamide Fragment Inhibitors That Induce Unprecedented Conformational Distortions in Enterovirus 71 3C and Sars-Cov-2 Main Protease. Acta Pharm Sin B V. 12 3924 2022.
ISSN: ISSN 2211-3835
PubMed: 35702321
DOI: 10.1016/J.APSB.2022.06.002
Page generated: Fri Aug 2 14:59:50 2024
|